Related Experiment Videos
Angiotensin, LDL peroxidation and atherosclerosis
1Lipid Research Laboratory, Rambam Medical Center, Rappaport Institute for Research in the Medical Sciences and The Bruce Rappaport Technion Faculty of Medicine, Haifa, Israel. skeidar@rambam.health.gov.il
Life Sciences
|July 17, 1998
Summary
Hypertension increases low-density lipoprotein (LDL) oxidation, a key factor in atherosclerosis. Angiotensin II (Ang-II) drives this process, but inhibiting Ang-II formation or its receptor may reduce atherosclerosis in hypertensive patients.
Area of Science:
- Cardiovascular Science
- Hypertension Research
- Atherosclerosis Pathogenesis
Background:
- Hypertension is a significant risk factor for atherosclerosis.
- While blood pressure reduction's impact on coronary artery disease is debated, specific interventions show promise in certain populations.
- Elevated plasma renin activity in hypertensive patients correlates with increased myocardial infarction risk.
Purpose of the Study:
- To investigate the relationship between hypertension and low-density lipoprotein (LDL) oxidation.
- To explore the role of angiotensin II (Ang-II) in LDL oxidation and atherogenesis in hypertensive patients.
Main Methods:
- Compared LDL oxidative modification propensity in hypertensive versus normotensive subjects.
- Assessed the effect of Ang-II on macrophage lipid peroxidation and LDL oxidation in vitro and in vivo.
- Investigated the impact of angiotensin-converting enzyme (ACE) inhibitors and an Ang-II receptor antagonist (Losartan) on LDL peroxidation and atherosclerosis in mice.
Main Results:
- LDL from hypertensive patients exhibited increased susceptibility to oxidative modification.
- Ang-II enhanced macrophage lipid peroxidation and LDL oxidation in a dose-dependent manner, mediated by Ang-II receptor binding.
- ACE inhibitors and Losartan significantly reduced LDL peroxidation and atherosclerotic lesions in mice.
Conclusions:
- Angiotensin II plays a crucial role in promoting LDL oxidation and atherogenesis in hypertensive individuals.
- Inhibiting Ang-II formation or blocking its receptor may represent a therapeutic strategy to attenuate atherosclerosis in hypertension.